1. Medtech Insight
  2. >>Geography

New Anti-Corruption Focus In Mexico May Include Medtech Scrutiny

 
• By Elizabeth Orr

Recently inaugurated Mexican President Andrés Manuel López Obrador campaigned on a promise to tackle the country’s corruption issues. Medtech Insight spoke to attorney Nicholas Berg, of Ropes & Gray, about what this may mean for device manufacturers doing business in Mexico.

New Mexican President Andres Manuel Lopez Obrador during an Indigenous ceremony as part of ceremony of the takeover as the new President of Mexico on December 01, 2018 in Mexico City - Image
New Mexican President Andres Manuel Lopez Obrador during an Indigenous ceremony as part of his inauguration on Dec. 1, 2018, in Mexico City. • Source: Shutterstock

New Mexican president Andrés Manuel López Obrador was swept into office last year on an anticorruption platform. Some observers expect his efforts to include reforms and increased regulation touching the medical device sector.

López Obrador, who was sworn into office Dec. 1, is a member of the National Regeneration Movement (MORENA) party. The...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Latin America

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 
• By Brian Bossetta

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.

China Strikes Back After Trump Ups Tariffs; Administration Further Delays Tariffs On Canada And Mexico

 
• By Brian Bossetta

In response to the Trump administration increasing its tariffs on imports from China, Beijing announced a ban on gene sequencers from US biotech firm Illumina, signaling a full-blown trade war could be in the making. Trump also pushed the deadline for implementing tariffs on Canada and Mexico back by another month.

PathAI Enters South American Market Partnering With Integrated Healthcare Network Rede D’or

 
• By Natasha Barrow

PathAI, a Boston-based AI-pathology startup backed by $355m, partners with Brazil’s largest integrated healthcare network to support diagnosis and treatment of cancer patients using its AISight image management system.

More from Geography